» Articles » PMID: 35190946

Predicting Counterfactual Risks Under Hypothetical Treatment Strategies: an Application to HIV

Overview
Journal Eur J Epidemiol
Specialty Public Health
Date 2022 Feb 22
PMID 35190946
Authors
Affiliations
Soon will be listed here.
Abstract

The accuracy of a prediction algorithm depends on contextual factors that may vary across deployment settings. To address this inherent limitation of prediction, we propose an approach to counterfactual prediction based on the g-formula to predict risk across populations that differ in their distribution of treatment strategies. We apply this to predict 5-year risk of mortality among persons receiving care for HIV in the U.S. Veterans Health Administration under different hypothetical treatment strategies. First, we implement a conventional approach to develop a prediction algorithm in the observed data and show how the algorithm may fail when transported to new populations with different treatment strategies. Second, we generate counterfactual data under different treatment strategies and use it to assess the robustness of the original algorithm's performance to these differences and to develop counterfactual prediction algorithms. We discuss how estimating counterfactual risks under a particular treatment strategy is more challenging than conventional prediction as it requires the same data, methods, and unverifiable assumptions as causal inference. However, this may be required when the alternative assumption of constant treatment patterns across deployment settings is unlikely to hold and new data is not yet available to retrain the algorithm.

Citing Articles

Risk-Based Decision Making: Estimands for Sequential Prediction Under Interventions.

Luijken K, Morzywolek P, van Amsterdam W, Cina G, Hoogland J, Keogh R Biom J. 2024; 66(8):e70011.

PMID: 39607308 PMC: 11604027. DOI: 10.1002/bimj.70011.


Development of a prediction model for 30-day COVID-19 hospitalization and death in a national cohort of Veterans Health Administration patients-March 2022-April 2023.

Bui D, Bajema K, Huang Y, Yan L, Li Y, Rajeevan N PLoS One. 2024; 19(10):e0307235.

PMID: 39365775 PMC: 11451987. DOI: 10.1371/journal.pone.0307235.


Prediction Under Interventions: Evaluation of Counterfactual Performance Using Longitudinal Observational Data.

Keogh R, van Geloven N Epidemiology. 2024; 35(3):329-339.

PMID: 38630508 PMC: 11332371. DOI: 10.1097/EDE.0000000000001713.


Delayed versus primary closure to minimize risk of surgical-site infection for complicated appendicitis: A secondary analysis of a randomized trial using counterfactual prediction modeling.

Tansawet A, Siribumrungwong B, Techapongsatorn S, Numthavaj P, Poprom N, Mckay G Infect Control Hosp Epidemiol. 2023; 45(3):322-328.

PMID: 37929568 PMC: 10933508. DOI: 10.1017/ice.2023.214.


Cohort profile: the Turin prostate cancer prognostication (TPCP) cohort.

Destefanis N, Fiano V, Milani L, Vasapolli P, Fiorentino M, Giunchi F Front Oncol. 2023; 13:1242639.

PMID: 37869094 PMC: 10587560. DOI: 10.3389/fonc.2023.1242639.


References
1.
Dahabreh I, Robertson S, Steingrimsson J, Stuart E, Hernan M . Extending inferences from a randomized trial to a new target population. Stat Med. 2020; 39(14):1999-2014. DOI: 10.1002/sim.8426. View

2.
Steingrimsson J, Gatsonis C, Li B, Dahabreh I . Transporting a Prediction Model for Use in a New Target Population. Am J Epidemiol. 2022; 192(2):296-304. PMC: 11004796. DOI: 10.1093/aje/kwac128. View

3.
Tate J, Sterne J, Justice A . Albumin, white blood cell count, and body mass index improve discrimination of mortality in HIV-positive individuals. AIDS. 2019; 33(5):903-912. PMC: 6749990. DOI: 10.1097/QAD.0000000000002140. View

4.
VanderWeele T, Hernan M . Causal Inference Under Multiple Versions of Treatment. J Causal Inference. 2014; 1(1):1-20. PMC: 4219328. DOI: 10.1515/jci-2012-0002. View

5.
Hernan M, Robins J . Per-Protocol Analyses of Pragmatic Trials. N Engl J Med. 2017; 377(14):1391-1398. DOI: 10.1056/NEJMsm1605385. View